Dr Ana Viñuela
Dr Alison Heggie
Donna McEvoy
Professor Mark Walker
| Author Correction: Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models (Nature Biotechnology, (2023), 41, 3, (399-408), 10.1038/s41587-022-01520-x) | 2023 |
|
Dr Alison Heggie
Donna McEvoy
Dr Ana Viñuela
Professor Mark Walker
| Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT Study | 2021 |
|
Donna McEvoy
Dianne Wake
Dr Alison Heggie
Dr Harshal Deshmukh
| A reference map of potential determinants for the human serum metabolome | 2020 |
|
Professor Mark Walker
Dr Alison Heggie
Dr Ana Viñuela
| Post-load glucose subgroups and associated metabolic traits in individuals with type 2 diabetes: An IMI-DIRECT study | 2020 |
|
Dr David Woods
Dr R Neely
Dr Katherine Talks
Dr Alison Heggie
Dr Richard Quinton
et al. | Hematopoiesis Shows Closer Correlation with Calculated Free Testosterone in Men than Total Testosterone | 2017 |
|
Dr Alison Heggie
Professor Mark Walker
| Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes | 2017 |
|
Dr Alison Heggie
Professor Mark Walker
| A patient with a glucokinase mutation: a cautionary tale | 2016 |
|
Dr Audrey Brown
Meutia Kumaheri
Dr Helen Porteous
Dr Alison Heggie
Dr Satomi Miwa
et al. | Age-Related Mitochondrial DNA Depletion and the Impact on Pancreatic Beta Cell Function | 2014 |
|
Dr Alison Heggie
Professor Mark Walker
| Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium | 2014 |
|
Dr Alison Heggie
Professor Mark Walker
| Renal function in patients with Type 2 diabetes treated with glucagon-like peptide 1 (GLP-1) analogues | 2013 |
|
